Diagnosis and Treatment of Pouchitis

Overview

Journal Gastroenterol Hepatol (N Y)

Specialty Gastroenterology

Date 2011 Sep 10

PMID 21904509

Citations 15

Authors

Bo Shen

Bret A Lashner

Affiliations

Soon will be listed here.

Abstract

Ileal pouch-anal anastomosis following total proctocolectomy has become part of the standard surgical treatment for patients with ulcerative colitis or familial adenomatous polyposis who require colectomy. Although this surgery has improved patient quality of life and significantly reduced the risk of dysplasia or neoplasia in ulcerative colitis patients, complications are common. Pouchitis is the most common long-term complication of ileal pouch surgery and has a significant adverse impact on patient quality of life. The diagnosis and differential diagnosis of pouchitis are not straightforward, and the management of pouchitis, particularly chronic antibiotic-refractory pouchitis, which is one of the leading causes of pouch failures, can be challenging.

Citing Articles

Pouch outcomes after minimally invasive vs. open proctectomy during IPAA reconstruction.

Metzger D, Mesiti A, Johnson J, Li Y, Brouwer J, Manasa M Surg Endosc. 2025; .

PMID: 39979620 DOI: 10.1007/s00464-025-11574-y.

Prevalence of Active Pouch Symptoms and Patient Perception of Symptom Control and Quality of Life in an Outpatient Practice.

Kirsch P, Rauch J, Delau O, Axelrad J, Chang S, Shaukat A Gastro Hep Adv. 2024; 3(8):1069-1078.

PMID: 39529641 PMC: 11550738. DOI: 10.1016/j.gastha.2024.07.019.

Evaluating the Relationship Between Nutrition and Post-colectomy Pouchitis in Pediatric Patients with Ulcerative Colitis.

Patel P, Kao E, Stekol E, Heyman M, Vu L, Verstraete S Dig Dis Sci. 2023; 68(6):2188-2195.

PMID: 36807017 PMC: 11017704. DOI: 10.1007/s10620-023-07872-x.

Inflammatory bowel disease-specific findings are common morphological changes in the ileal pouch with ulcerative colitis.

Toritani K, Kimura H, Otani M, Fukuoka H, Kunisaki R, Watanabe J Sci Rep. 2022; 12(1):20361.

PMID: 36437274 PMC: 9701810. DOI: 10.1038/s41598-022-24708-2.

α4β7 integrin-dependent adhesion of T cells to MAdCAM-1 is blocked by vedolizumab in patients with chronic refractory pouchitis.

Melde M, Muller T, Schneider I, Geppert C, Muhl L, Besendorf L Therap Adv Gastroenterol. 2021; 14:17562848211054707.

PMID: 34868349 PMC: 8640978. DOI: 10.1177/17562848211054707.

References

Schmidt C, Giese T, Ludwig B, Menges M, Schilling M, Meuer S . Increased cytokine transcripts in pouchitis reflect the degree of inflammation but not the underlying entity. Int J Colorectal Dis. 2005; 21(5):419-26. DOI: 10.1007/s00384-005-0024-2. View

Casadesus D, Tani T, Wakai T, Maruyama S, Iiai T, Okamoto H . Possible role of human cytomegalovirus in pouchitis after proctocolectomy with ileal pouch-anal anastomosis in patients with ulcerative colitis. World J Gastroenterol. 2007; 13(7):1085-9. PMC: 4146872. DOI: 10.3748/wjg.v13.i7.1085. View

Duffy M, OMahony L, Coffey J, Collins J, Shanahan F, Redmond H . Sulfate-reducing bacteria colonize pouches formed for ulcerative colitis but not for familial adenomatous polyposis. Dis Colon Rectum. 2002; 45(3):384-8. DOI: 10.1007/s10350-004-6187-z. View

Achkar J, Al-Haddad M, Lashner B, Remzi F, Brzezinski A, Shen B . Differentiating risk factors for acute and chronic pouchitis. Clin Gastroenterol Hepatol. 2005; 3(1):60-6. DOI: 10.1016/s1542-3565(04)00604-4. View

Stahlberg D, Gullberg K, Liljeqvist L, Hellers G, Lofberg R . Pouchitis following pelvic pouch operation for ulcerative colitis. Incidence, cumulative risk, and risk factors. Dis Colon Rectum. 1996; 39(9):1012-8. DOI: 10.1007/BF02054692. View

Fazio V, Ziv Y, Church J, Oakley J, Lavery I, Milsom J . Ileal pouch-anal anastomoses complications and function in 1005 patients. Ann Surg. 1995; 222(2):120-7. PMC: 1234769. DOI: 10.1097/00000658-199508000-00003. View

Miner P, Wedel M, Bane B, Bradley J . An enema formulation of alicaforsen, an antisense inhibitor of intercellular adhesion molecule-1, in the treatment of chronic, unremitting pouchitis. Aliment Pharmacol Ther. 2004; 19(3):281-6. DOI: 10.1111/j.1365-2036.2004.01863.x. View

Gionchetti P, Rizzello F, Helwig U, Venturi A, Lammers K, Brigidi P . Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology. 2003; 124(5):1202-9. DOI: 10.1016/s0016-5085(03)00171-9. View

Kuisma J, Jarvinen H, Kahri A, Farkkila M . Factors associated with disease activity of pouchitis after surgery for ulcerative colitis. Scand J Gastroenterol. 2004; 39(6):544-8. DOI: 10.1080/00365520410004668. View

10.

Ulisse S, Gionchetti P, DAlo S, Russo F, Pesce I, Ricci G . Expression of cytokines, inducible nitric oxide synthase, and matrix metalloproteinases in pouchitis: effects of probiotic treatment. Am J Gastroenterol. 2001; 96(9):2691-9. DOI: 10.1111/j.1572-0241.2001.04139.x. View

11.

Viscido A, Kohn A, Papi C, Caprilli R . Management of refractory fistulizing pouchitis with infliximab. Eur Rev Med Pharmacol Sci. 2005; 8(5):239-46. View

12.

Schmidt C, Lazenby A, Hendrickson R, Sitzmann J . Preoperative terminal ileal and colonic resection histopathology predicts risk of pouchitis in patients after ileoanal pull-through procedure. Ann Surg. 1998; 227(5):654-62; discussion 663-5. PMC: 1191341. DOI: 10.1097/00000658-199805000-00006. View

13.

Chaussade S, Denizot Y, Valleur P, NICOLI J, Raibaud P, GUERRE J . Presence of PAF-acether in stool of patients with pouch ileoanal anastomosis and pouchitis. Gastroenterology. 1991; 100(6):1509-14. DOI: 10.1016/0016-5085(91)90646-3. View

14.

Isaacs K, Sandler R, Abreu M, Picco M, Hanauer S, Bickston S . Rifaximin for the treatment of active pouchitis: a randomized, double-blind, placebo-controlled pilot study. Inflamm Bowel Dis. 2007; 13(10):1250-5. DOI: 10.1002/ibd.20187. View

15.

Shepherd N, Hulten L, Tytgat G, Nicholls R, Nasmyth D, Fernandez F . Pouchitis. Int J Colorectal Dis. 1989; 4(4):205-29. DOI: 10.1007/BF01644986. View

16.

Gionchetti P, Campieri M, Belluzzi A, Bertinelli E, Ferretti M, Brignola C . Mucosal concentrations of interleukin-1 beta, interleukin-6, interleukin-8, and tumor necrosis factor-alpha in pelvic ileal pouches. Dig Dis Sci. 1994; 39(7):1525-31. DOI: 10.1007/BF02088059. View

17.

Gertner D, Rampton D, Madden M, Talbot I, Nicholls R, Lennard-Jones J . Increased leukotriene B4 release from ileal pouch mucosa in ulcerative colitis compared with familial adenomatous polyposis. Gut. 1994; 35(10):1429-32. PMC: 1375019. DOI: 10.1136/gut.35.10.1429. View

18.

Goldberg P, Herbst F, Beckett C, Martelli B, Kontakou M, Talbot I . Leucocyte typing, cytokine expression, and epithelial turnover in the ileal pouch in patients with ulcerative colitis and familial adenomatous polyposis. Gut. 1996; 38(4):549-53. PMC: 1383113. DOI: 10.1136/gut.38.4.549. View

19.

Sandborn W . Pouchitis following ileal pouch-anal anastomosis: definition, pathogenesis, and treatment. Gastroenterology. 1994; 107(6):1856-60. DOI: 10.1016/0016-5085(94)90832-x. View

20.

Hui T, Landers C, Vasiliauskas E, Abreu M, Dubinsky M, Papadakis K . Serologic responses in indeterminate colitis patients before ileal pouch-anal anastomosis may determine those at risk for continuous pouch inflammation. Dis Colon Rectum. 2005; 48(6):1254-62. DOI: 10.1007/s10350-005-0013-0. View